These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. London's disastrous drug trial has serious side effects for research. Wadman M Nature; 2006 Mar; 440(7083):388-9. PubMed ID: 16554763 [No Abstract] [Full Text] [Related]
4. FDA to vet embryonic stem cells' safety. Baker M Nature; 2008 Apr; 452(7188):670. PubMed ID: 18401364 [No Abstract] [Full Text] [Related]
5. Moment of reckoning. Wadman M Nature; 2007 Apr; 446(7138):844-5. PubMed ID: 17443154 [No Abstract] [Full Text] [Related]
6. FDA penalizes trial misconduct. Shaffer C Nat Biotechnol; 2009 Oct; 27(10):872. PubMed ID: 19816424 [No Abstract] [Full Text] [Related]
13. [Side effects of a desastrous clinical trial]. Gilgenkrantz S Med Sci (Paris); 2006 May; 22(5):557-8. PubMed ID: 16687128 [No Abstract] [Full Text] [Related]
14. New clinical trials policy at FDA. Vastag B Nat Biotechnol; 2006 Sep; 24(9):1043. PubMed ID: 16964196 [No Abstract] [Full Text] [Related]
15. FDA insists on more women in drug trials. Josefson D BMJ; 1997 Oct; 315(7112):833. PubMed ID: 9353497 [No Abstract] [Full Text] [Related]
16. The right to a trial: Should dying patients have access to experimental drugs? Groopman J New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539 [No Abstract] [Full Text] [Related]
17. Natalizumab (Tysabri) returns. Med Lett Drugs Ther; 2006 Sep; 48(1243):76. PubMed ID: 16977289 [No Abstract] [Full Text] [Related]